Department of Health Sciences, Lund University, Lund, Sweden.
Institute for Palliative Care, Lund University and Region Skåne, Lund, Sweden.
Eur J Epidemiol. 2024 Sep;39(9):1063-1071. doi: 10.1007/s10654-024-01151-3. Epub 2024 Sep 23.
The aim of the creation of this cohort was to investigate patterns of health and health care utilisation before and during the COVID-19 pandemic, overall and in relation to specific diagnoses, among people with intellectual disabilities (ID) compared to the general population. People living in Skåne, the southernmost region of Sweden, on 1st of January 2014 with at least one diagnosis of ID (ICD-10 codes F70-F79) or Down syndrome (DS; Q90), or support and/or services according to the LSS act comprised the ID cohort (n = 14 716). People living in the same family and/or household as a person in the ID cohort constituted the ID family cohort (n = 31 688), and those remaining comprised the general population cohort (gPop; n = 1 226 955). Data has been collected for all three cohorts from several national and regional registers. These include registers for health care (2014-2021), deaths (2014-2021), COVID-19-related health care (vaccinations, intensive care, palliative care, 2020-2021). The prevalence of ID was 1.2%. In the ID cohort, 77.9% had at least one measure of support, 5.8% at least one Q90-diagnosis and 63.8% had at least one F7-diagnosis (26.9% mild (F70), 7.4% moderate (F71), 2.8% severe (F72), 1.4% profound (F73), and 25.4% other/unknown (F78/F79)). Compared to the gPop there were more people in the younger age groups in the ID cohort. At this point, no additional collection of data will be carried out. However, there is a possibility to add data from the registers to include years after 2021 or from additional registers. Future publications will explore relevant research questions and report key findings in relation to health among people with ID. Future results will be used to inform policy and practice on people with ID.
本队列研究的目的是调查与一般人群相比,智力残疾(ID)人群在 COVID-19 大流行前后的健康状况和医疗保健利用模式,以及特定诊断的相关模式。2014 年 1 月 1 日居住在瑞典最南部斯科讷地区、至少有一个 ID 诊断(ICD-10 代码 F70-F79)或唐氏综合征(DS;Q90)或根据 LSS 法案获得支持和/或服务的人,构成 ID 队列(n=14716)。与 ID 队列中的人居住在同一家庭和/或家庭中的人构成 ID 家庭队列(n=31688),其余的人构成一般人群队列(gPop;n=1226955)。所有三个队列的数据均从多个国家和地区登记处收集。这些登记处包括医疗保健登记处(2014-2021 年)、死亡登记处(2014-2021 年)、COVID-19 相关医疗保健登记处(疫苗接种、重症监护、姑息治疗,2020-2021 年)。ID 的患病率为 1.2%。在 ID 队列中,77.9%的人至少有一项支持措施,5.8%的人至少有一项 Q90 诊断,63.8%的人至少有一项 F7 诊断(26.9%轻度(F70),7.4%中度(F71),2.8%严重(F72),1.4%深度(F73)和 25.4%其他/未知(F78/F79))。与 gPop 相比,ID 队列中的年轻人更多。目前,不会再进行额外的数据收集。但是,有可能从登记处添加 2021 年后的数据或来自其他登记处的数据。未来的出版物将探讨与 ID 人群健康相关的相关研究问题,并报告关键发现。未来的结果将用于为 ID 人群的政策和实践提供信息。